NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 59 filers reported holding NEOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $79,000 | +54.9% | 30,250 | -1.8% | 0.00% | – |
| Q4 2018 | $51,000 | -44.0% | 30,814 | +63.9% | 0.00% | – |
| Q3 2018 | $91,000 | -19.5% | 18,798 | +4.2% | 0.00% | – |
| Q2 2018 | $113,000 | -13.7% | 18,037 | +14.0% | 0.00% | – |
| Q1 2018 | $131,000 | -22.9% | 15,819 | -5.1% | 0.00% | -100.0% |
| Q4 2017 | $170,000 | +44.1% | 16,669 | +29.1% | 0.00% | – |
| Q3 2017 | $118,000 | +35.6% | 12,909 | +8.1% | 0.00% | – |
| Q2 2017 | $87,000 | +40.3% | 11,944 | +38.5% | 0.00% | – |
| Q1 2017 | $62,000 | +34.8% | 8,621 | +9.1% | 0.00% | – |
| Q4 2016 | $46,000 | -99.9% | 7,901 | -0.3% | 0.00% | – |
| Q3 2016 | $52,133,000 | -29.0% | 7,923 | +0.2% | 0.00% | – |
| Q2 2016 | $73,414,000 | +115.9% | 7,911 | +148.1% | 0.00% | – |
| Q1 2016 | $34,000,000 | – | 3,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 666,729 | $14,008,000 | 9.60% |
| DSC Advisors, L.P. | 907,358 | $17,157,000 | 8.33% |
| DAFNA Capital Management LLC | 63,400 | $1,332,000 | 1.32% |
| WALL STREET ASSOCIATES | 199,343 | $4,188,000 | 0.80% |
| Perceptive Advisors | 742,132 | $15,592,000 | 0.62% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 331,142 | $6,957,000 | 0.46% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 458,332 | $9,630,000 | 0.37% |
| EMERALD ADVISERS, LLC | 321,313 | $6,751,000 | 0.35% |
| Tourbillon Capital Partners, L.P. | 611,686 | $12,852,000 | 0.34% |
| DSC Advisors, L.P. | 31,240 | $656,000 | 0.32% |